GlassScriptPhysician profile
Ji Yeon Lee
NPI 1316235435
$8,519.74
in general payments reported to CMS, 2019-2025
43 companies · $2,755 in 2025
The $2,755 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,138 · 2020: $833 · 2021: $903 · 2022: $924 · 2023: $615 · 2024: $1,351 · 2025: $2,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,721.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,397.18 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,052.40 | 2019-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $964.38 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Genzyme Corporation | $612.72 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $485.81 | 2021-2025 | Dupixent |
| Insmed, INC. | $425.92 | 2019-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $350.61 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $309.63 | 2020-2025 | Acthar |
| Baxter Healthcare | $263.24 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $263.14 | 2019-2023 | Yupelri |
| Philips North America LLC | $237.64 | 2020-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Harmony Biosciences LLC | $234.40 | 2020-2025 | Wakix |
| Amgen INC. | $232.71 | 2021-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $155.24 | 2020-2025 | |
| Viatris Specialty LLC | $153.93 | 2025 | Yupelri |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $141.88 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $104.00 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $103.29 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $83.13 | 2024-2025 | Lumryz |
| Electromed, INC. | $81.78 | 2022-2024 | Smartvest |
| Abbvie INC. | $78.88 | 2023-2025 | |
| Advanced Respiratory, INC | $60.16 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.71 | 2021-2025 | Glassia |
| Gilead Sciences, INC. | $58.69 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $56.68 | 2019 | |
| Axsome Therapeutics, INC. | $56.43 | 2025 | Sunosi |
| Merck Sharp & Dohme LLC | $54.10 | 2023-2025 | |
| Shire North American Group INC | $53.31 | 2019 | |
| Genentech USA, INC. | $50.77 | 2019-2023 | Rozlytrek, Gavreto, Alecensa |
| Actelion Pharmaceuticals US, INC. | $47.56 | 2024-2025 | Opsumit |
| Novartis Pharmaceuticals Corporation | $35.81 | 2022 | |
| Eisai INC. | $32.62 | 2021 | |
| Resmed Corp | $30.69 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $28.48 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $21.64 | 2024 | Quviviq |
| La Jolla Pharmaceutical Company | $20.96 | 2023 | Giapreza |
| Pulmonx Corporation | $19.21 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Ani Pharmaceuticals, INC. | $18.74 | 2025 | Purified Cortrophin Gel |
| Arbor Pharmaceuticals, INC. | $18.05 | 2019 | |
| Inogen, INC. | $17.94 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Paratek Pharmaceuticals, INC. | $17.85 | 2020 | |
| Pfizer INC. | $15.38 | 2022 | |
| Circassia INC. | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ji Yeon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.